IP Library Granted Patent US 9,388,154
Granted Patent B2
US 9,388,154 · App. 14/343,550 · Granted Jul 12, 2016

Process for preparing synthetic prostacyclins

Inventors: George Petros Yiannikouros (Florence, SC); Panos Kalaritis (Florence, SC); Chaminda Priyapushpa Gamage (Florence, SC); Denis Viktorovich Arefyev (Florence, SC)
Assignee: Lund Biotechnology PBC
C07D307/93A61K31/557A61K31/5575A61K31/5578A61K31/5585C07C67/31C07C67/313C07C405/00C07C2101/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,388,154
App. No.
14/343,550
Granted
Jul 12, 2016
Kind
B2
Abstract

The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogs, including Beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in these methods.

Claims (77)

1. A method for preparing a synthetic prostacyclin or a synthetic intermediate thereof, wherein the method comprises contacting an aldehyde with an enantiomerically pure phosphonate in a Horner-Emmons reaction to provide an alkene,

wherein the enantiomerically pure phosphonate has a structure:

wherein R″ and R′″ are alkyl; and

wherein the synthetic prostacyclin or synthetic intermediate thereof is produced as a single isomer.

2. The method of claim 1 , wherein the aldehyde is a product of the ozonolysis of a compound of formula (V), (V′) or (V″):

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent;

X 3 is H or an alkyl group substituent;

A is —O—, —S—, or —CH 2 —; and

Y and Z are hydroxyl protecting groups, which can be the same or different;

or a stereoisomer thereof.

3. The method of claim 2 , wherein R is —CO 2 R′, —(CH 2 ) n —CO 2 R′, —O—(CH 2 ) n —CO 2 R′, or —CH 2 ═CH 2 —(CH 2 ) n —CO 2 R′, wherein n is an integer between 1 and 8 and R′ is H, unsubstituted alkyl, substituted alkyl, aryl, or substituted aryl.

4. The method of claim 2 , wherein Y and Z are each —C(═O)CH 3 .

5. The method of claim 2 , wherein the aldehyde is the product of the ozonolysis of a compound of formula (V):

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent; and

Y and Z are hydroxyl protecting groups, which can be the same or different;

or a stereoisomer thereof.

6. The method of claim 5 , wherein the compound of formula (V) is the compound:

or a stereoisomer thereof.

7. The method of claim 1 , further comprising stereoselectively reducing a ketone in the alkene compound formed during the Horner-Emmons reaction.

8. The method of claim 7 , wherein the stereoselective reduction is performed using a Corey-Bakshi-Shibata (CBS) catalyst.

9. The method of claim 1 , further comprising deprotecting protected hydroxyl groups.

10. The method of claim 1 , wherein the synthetic prostacyclin is Beraprost.

11. A synthetic prostacyclin or synthetic intermediate thereof, prepared according to the method of claim 1 .

12. A synthetic prostacyclin prepared according to the method of claim 1 , wherein the synthetic prostacyclin is a single isomer of Beraprost.

13. A method for preparing a synthetic prostacyclin or synthetic intermediate thereof, wherein the method comprises:

(a) providing a compound of formula (V), (V′) or (V″):

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent;

X 3 is H or an alkyl group substituent;

A is —O—, —S—, or —CH 2 —; and

Y and Z are hydroxyl protecting groups, which can be the same or different;

or a stereoisomer thereof;

(b) deprotecting the compound of formula (V), (V′) or (V″) to provide a diol comprising a primary alcohol and a secondary alcohol; and

(c) selectively oxidizing the primary alcohol of the diol to provide an aldehyde-containing compound of one of formulas (XIII), (XIII′) or (XIII″):

or a stereoisomer thereof, wherein R, X 1 , X 2 , X 3 , and A are as defined for the compounds of formulas (V), (V′), and (V″).

14. A method for producing a compound of formula (V), wherein the method comprises:

(a) coupling compound A:

or a stereoisomer thereof, and

a compound of formula (B):

wherein:

X is halo,

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted; and

X 1 and X 2 are independently H or an aryl group substituent;

(b) cyclizing the product of step (a) to form a cyclized compound;

(c) reducing a ketone group in the cyclized compound to form a compound comprising a secondary alcohol; and

(d) performing an oxidative rearrangement of the compound prepared in step (c) or a compound prepared by protecting the secondary alcohol group of the compound prepared in step (c).

15. A method for preparing a synthetic prostacyclin or synthetic intermediate thereof, wherein the method comprises the use of a synthetic intermediate of formula (V), (V′), or (V″) or a hydroxyl group deprotected derivative thereof, wherein formulas (V), (V′), and (V″) are:

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent;

X 3 is H or an alkyl group substituent;

A is —O—, —S—, or —CH 2 —; and

Y and Z are hydroxyl protecting groups, which can be the same or different; or a stereoisomer thereof, and

wherein the hydroxyl group deprotected derivative thereof is a compound of one of formulas (V), (V′), and (V″) wherein one or both of Z and Y are replaced by a hydrogen atom.

16. A compound of formula (V), (V′), or (V″) or a hydroxyl group deprotected derivative thereof, wherein formulas (V), (V′), and (V″) are:

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent;

X 3 is H or an alkyl group substituent;

A is —O—, —S—, or —CH 2 —; and

Y and Z are hydroxyl protecting groups, which can be the same or different; or a stereoisomer thereof, and

wherein the hydroxyl group deprotected derivative thereof is a compound of one of formulas (V), (V′), and (V″) wherein one or both of Z and Y are replaced by a hydrogen atom.

17. A method for preparing an intermediate for a synthetic prostacyclin, wherein the method comprises contacting compound A:

or a stereoisomer and/or analog thereof with a halogenated coupling precursor molecule in a coupling reaction to provide a coupled halogenated molecule.

18. A compound of formula (XIV), (XIV′), or (XIV″):

wherein:

R is a directly attached carboxylic acid or ester group or is a carboxylic acid or ester group attached via an aliphatic linker, optionally wherein the aliphatic linker is branched or substituted;

X 1 and X 2 are independently H or an aryl group substituent;

X 3 is H or an alkyl group substituent; and

A is —O—, —S—, or —CH 2 —;

or a stereoisomer thereof.

19. A method of preparing a synthetic prostacyclin, wherein the method comprises alkylating a compound of formula (XIV), (XIV′), or (XIV″).

Assignments (2)
CHANGE OF NAME Recorded May 5, 2015
From: LUNG BIOTECHNOLOGY INC.
To: LUNG BIOTECHNOLOGY PBC
Reel/Frame 035574/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2014
From: YIANNIKOUROS, GEORGE PETROS; KALARITIS, PANOS; GAMAGE, CHAMINDA PRIYAPUSHPA; AREFYEV, DENIS VIKTOROVICH
To: LUNG BIOTECHNOLOGY INC.
Reel/Frame 033524/0907 →
Continuity (2)
Provisional Application 61533622 · Sep 12, 2011
Related Publication 20150025255A1 · Jan 22, 2015